Fundz

Optimize Rx Corp reported raising $9 Million in an initial SEC Form D filing, from an offering of $9 Million

PUBLIC · OPRXMay 11, 2018

Amount Raised

$9 Million

$9 Million sold, per SEC Form D (first sale May 11, 2018)

Round Type

Venture

WalthamHealthcareHealth Care

Quick answer

OptimizeRx raised $9 Million in a funding round, dated May 11, 2018. OptimizeRx is based in Waltham, Massachusetts, United States.

How much did OptimizeRx raise?
OptimizeRx raised $9 Million in a funding round on May 11, 2018.
What does OptimizeRx do?
OptimizeRx® (OPRX) provides unique physician and consumer platforms and strategies to help patients better afford and adhere to their treatment regimens, while offering pharmaceutical and healthcare companies more..
Where is OptimizeRx based and how big is it?
OptimizeRx is based in Waltham, Massachusetts, United States. Fundz records about 132 employees.
Who are the decision-makers at OptimizeRx?
Fundz holds 1 contact at OptimizeRx. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as OptimizeRx that raised within 45 days of this round, from Fundz verified event records.

  • Modify Health raised $125K (Pre-Seed) on June 21, 2018.
  • Acutus Medical raised $23M on June 14, 2018.
  • Azora Therapeutics, Inc. (DE) raised $325K on June 14, 2018.
  • Upgrade Labs raised $100K (Pre-Seed) on June 12, 2018.
  • Nuo Therapeutics raised $500K on June 12, 2018.
  • Purple Biotech raised $8.2M on June 7, 2018.

Who to call at OptimizeRx, and when

A new round usually means OptimizeRx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OptimizeRx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OptimizeRx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OptimizeRx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OptimizeRx

Location

Waltham, Massachusetts, United States

About

OptimizeRx® (OPRX) provides unique physician and consumer platforms and strategies to help patients better afford and adhere to their treatment regimens, while offering pharmaceutical and healthcare companies more effective ways to deliver relevant information and services to healthcare providers and their patients right at the point of care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OptimizeRx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts1 person is listed at OptimizeRx. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for OptimizeRx's next move

See what Strategic adds

OptimizeRx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.